A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Biochemical Journal

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BJ20021226PMID 12350228PMCID PMC1223066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Splitting image

  2020cited by this paper
• A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells

  2001cited by this paper
• Autophagic cell death and its execution by lysosomal cathepsins.

  2001cited by this paper
• Congenital ovine neuronal ceroid lipofuscinosis--a cathepsin D deficiency with increased levels of the inactive enzyme.

  2001cited by this paper
• Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer.

  2000cited by this paper
• Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons.

  2000cited by this paper
• A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration

  2000cited by this paper
• Cathepsin D Deficiency Induces Lysosomal Storage with Ceroid Lipofuscin in Mouse CNS Neurons

  2000cited by this paper
• Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases.

  1999cited by this paper
• Anti‐human procathepsin D activation peptide antibodies inhibit breast cancer development

  1999cited by this paper
• Alternative mechanisms for trafficking of lysosomal enzymes in mannose 6-phosphate receptor-deficient mice are cell type-specific.

  1999cited by this paper
• Mechanisms and kinetics of procathepsin D activation.

  1999cited by this paper
• Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC).

  1998cited by this paper
• Potential role for Cathepsin D in p53-dependent tumor suppression and chemosensitivity

  1998cited by this paper
• Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes

  1998cited by this paper
• Human and hamster procathepsin D, although equally tagged with mannose-6-phosphate, are differentially targeted to lysosomes in transfected BHK cells

  1998cited by this paper
• Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.

  1997cited by this paper
• Proteolysis of Insulin-Like Growth Factors (IGF) and IGF Binding Proteins by Cathepsin D.

  1997cited by this paper
• Cathepsin D protease mediates programmed cell death induced by interferon‐gamma, Fas/APO‐1 and TNF‐alpha.

  1996cited by this paper
• Families of aspartic peptidases, and those of unknown catalytic mechanism.

  1995cited by this paper
• The Two Mannose 6-Phosphate Receptors Transport Distinct Complements of Lysosomal Proteins (*)

  1995cited by this paper
• Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells.

  1995cited by this paper
• Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.

  1994cited by this paper
• Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells.

  1994cited by this paper
• Intermolecular association of lysosomal protein precursors during biosynthesis.

  1994cited by this paper
• Mannose 6-phosphate-independent targeting of lysosomal enzymes in I- cell disease B lymphoblasts

  1993cited by this paper
• Two crystal structures for cathepsin D: the lysosomal targeting signal and active site.

  1993cited by this paper
• Mannose 6-phosphate-independent targeting of cathepsin D to lysosomes in HepG2 cells.

  1991cited by this paper
• Procathepsins L and D are membrane-bound in acidic microsomal vesicles.

  1991cited by this paper
• Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency.

  1990cited by this paper
• The biogenesis of lysosomes.

  1989cited by this paper
• On the effects of weak bases and monensin on sorting and processing of lysosomal enzymes in human cells.

  1987cited by this paper
• 46-kDa mannose 6-phosphate-specific receptor: biosynthesis, processing, subcellular location and topology.

  1987cited by this paper
• Cloning and sequence analysis of cDNA for human cathepsin D.

  1985cited by this paper
• Enhanced degradation of cathepsin D synthesized in the presence of the threonine analog beta-hydroxynorvaline.

  1984cited by this paper
• Carboxyl-terminal proteolytic processing during biosynthesis of the lysosomal enzymes beta-glucuronidase and cathepsin D.

  1983cited by this paper
• Biosynthesis of a lysosomal enzyme. Partial structure of two transient and functionally distinct NH2-terminal sequences in cathepsin D.

  1981cited by this paper
• Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues.

  1980cited by this paper
• Biological activity of pepstatins, pepstanone A and partial peptides on pepsin, cathepsin D and renin.

  1972cited by this paper
• The FASEB Journal express article 10.1096/fj.00-0708fje. Published online May 18, 2001. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress

  year unknowncited by this paper

• Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis

  2022cites this paper
• Therapeutic landscape for Batten disease: current treatments and future prospects

  2019cites this paper
• The neuronal ceroid lipofuscinoses program: A translational research experience in Argentina.

  2015cites this paper
• Over‐expression of an inactive mutant cathepsin D increases endogenous alpha‐synuclein and cathepsin B activity in SH‐SY5Y cells

  2014cites this paper
• Apoptotic photoreceptor loss and altered expression of lysosomal proteins in the nclf mouse model of neuronal ceroid lipofuscinosis.

  2013cites this paper
• Cathepsin D: A Novel Target for Apoptotic Induction, as a Future Anti-Cancer Therapy: a Review

  2012cites this paper
• Human Aspartic Proteinases

  2011cites this paper
• Loss-of-function point mutations associated with renal tubular dysgenesis provide insights about renin function and cellular trafficking.

  2011cites this paper
• Isolation, biochemical characterization, and molecular modeling of American lobster digestive cathepsin D1.

  2010cites this paper
• A novel single-chain antibody fragment for detection of mannose 6-phosphate-containing proteins: application in mucolipidosis type II patients and mice.

  2010cites this paper
• Retention of lysosomal protein CLN5 in the endoplasmic reticulum causes neuronal ceroid lipofuscinosis in Asian Sibship

  2009cites this paper
• Neuronal ceroid lipofuscinoses.

  2009cites this paper
• Genetik und Pathobiochem

  2009cites this paper
• Cathepsin D--many functions of one aspartic protease.

  2008cites this paper
• Cathepsin D expression is decreased in Alzheimer's disease fibroblasts.

  2008cites this paper
• Profiling of proteolytic enzymes in the gut of the tick Ixodes ricinus reveals an evolutionarily conserved network of aspartic and cysteine peptidases

  2008cites this paper
• Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10)

  2008cites this paper
• IDENTIFICATION OF TWO NOVEL HUMAN NEURONAL CEROID LIPOFUSCINOSIS GENES

  2008cites this paper
• Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B.

  2006cites this paper
• High yield synthesis and characterization of phosphorylated recombinant human procathepsin D expressed in mammalian cells.

  2006cites this paper
• Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis.

  2006cites this paper
• Mutation of the glycosylated asparagine residue 286 in human CLN2 protein results in loss of enzymatic activity.

  2004cites this paper
• Communication Mutation of the glycosylated asparagine residue 286 in human CLN2 protein results in loss of enz ymatic activity

  2004cites this paper
• Purified recombinant human prosaposin forms oligomers that bind procathepsin D and affect its autoactivation.

  2004cites this paper
• Defective Endoplasmic Reticulum-resident Membrane Protein CLN6 Affects Lysosomal Degradation of Endocytosed Arylsulfatase A*

  2004cites this paper
• Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis

  2004cites this paper
• Untersuchung zur Pathogenese der neuronalen Ceroid-Lipofuszinosen am Menschen und an den Tiermodellen Ovis aries (LINNEAUS 1758) und Mus musculus (LINNEAUS 1758) : CLN6 und Cathepsin-D-Defizienz

  2003cites this paper
• Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis

  2003cites this paper
• Stress-induced apoptosis is impaired in cells with a lysosomal targeting defect but is not affected in cells synthesizing a catalytically inactive cathepsin D

  2003cites this paper
• Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis.

  2003cites this paper